EpiVax is a biotechnology Company located in Providence, Rhode Island, that uses cutting edge bioinformatics tools (more specifically, immunoinformatics tools such as the EpiMatrix algorithm) to improve the efficacy and safety of vaccines and biologic products (proteins such as Humira, Factor VIII, and Botox). EpiVax also has extensive internal programs focused on developing new methods for modulating the human immune response using its Tregitope Technology platform. Mission:?Our Mission: Innovating immunotherapy to improve global health through fearless science.
1 to 50 Employees
TypeCompany - Private
Revenue$1 to $5 million (USD)
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded1998